山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (5): 116-118.doi: 10.6040/j.issn.1671-7554.0.2020.1751
• • 上一篇
毕亚珍,冯洒然,李红,刘倩,于靖宜,王焱,朱传升
中图分类号:
[1] Lumachi F, Brunello A, Roma A, et al. Cancer-induced hypercalcemia[J]. Anticancer Res, 2009, 29(5):1551-1555. [2] Dunford JE. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition[J]. Curr Pharm Des, 2010, 16(27):2961-2969. doi:10.2174/138161210793563617. [3] Teixeira S, Branco L, Fernandes MH, et al. Bisphosphonates and Cancer: A relationship beyond the antiresorptive effects[J]. Mini Rev Med Chem, 2019, 19: 988-998. doi:10.2174/1389557519666190424163044. [4] 段铱, 王迪, 熊晶, 等. 以重度高钙血症为首发症状的成人急性B淋巴细胞白血病1例报道及治疗讨论[J].华中科技大学学报(医学版), 2013, 42(6):741-742. [5] Hu MI, Glezerman IG, Leboulleux S, et al. Denosumab for treatment of hypercalcemia of malignancy[J]. J Clin Endocrinol Metab, 2014, 99:3144-3152. doi:10.1210/jc.2014-1001. [6] Valdes-Socin H, Almanza MR, Fernandez-Ladreda MT, et al. Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumor[J]. Archiv Endocrinol Metab, 2017, 61: 506-509. doi:10.1590/2359-3997000000291. [7] Sternlicht H, Glezerman IG. Hypercalcemia of malignancy and new treatment options[J]. Ther Clin Risk Manag, 2015,11:1779-1788. doi:10.2147/TCRM.S83681. [8] Asonitis N, Angelousi A, Zafeiris C, et al. Diagnosis, pathophysiology and management of hypercalcemia in malignancy: A review of the literature[J]. Horm Metab Res, 2019, 51(12):770-778. [9] Zagzag J, Hu MI, Fisher SB, et al. Hypercalcemia and cancer: Differential diagnosis and treatment[J]. CA-Cancer J Clin, 2018, 68: 377-386. doi:10.3322/caac.21489. [10] Goldner W. Cancer-related hypercalcemia[J]. J Oncol Pract, 2016, 12, 426-432. doi:10.1200/JOP.2016.011155. [11] Dellay B, Groth M. Emergency management of malignancy-associated hypercalcemia[J]. Adv Emerg Nurs J, 2016, 38(1):15-25. doi:10.1097/TME.0000000000000093. |
[1] | 张晓慧,罗建民,索晓慧,孙国锋,李静. 抑癌基因SOCS1、SOCS3的甲基化与急性髓系白血病患者治疗转归及预后的关联分析[J]. 山东大学学报 (医学版), 2021, 59(3): 67-73. |
[2] | 杨娟, 邱宗建, 宋强. 辛伐他汀对急性髓系白血病NB4细胞株DNA甲基转移酶的影响[J]. 山东大学学报(医学版), 2015, 53(6): 28-32. |
[3] | 尹冬梅1,许洪志1,张婧瑶1,隋潇徽1,崔彬2,马春燕2,甄长青1. AA、MDS和AML患者CD4+T细胞亚群的变化及其临床意义[J]. 山东大学学报(医学版), 2012, 50(3): 66-70. |
[4] | 孔海丽,马道新,张晶晶,王慧君,刘传方. PDCD4、TGF-β1在急性髓系白血病患者骨髓中的表达及意义[J]. 山东大学学报(医学版), 2011, 49(6): 110-114. |
|